Financial Data and Key Metrics Changes - The company reported second quarter organic sales growth of 0.6% despite an uncertain macro environment, with adjusted EPS growing 5% to $0.80, slightly ahead of guidance [6][10] - Adjusted EBITDA margin expanded by 30 basis points to 17.2%, driven by favorable mix, productivity initiatives, and disciplined discretionary spending [6][10] - For the first half of the year, organic sales grew about 1%, with expectations for a similar demand environment in the second half [7][10] Business Line Data and Key Metrics Changes - The Color Additives and Inks segment saw adjusted EBITDA grow 4% on 2% lower organic sales, with weaker demand in consumer and transportation markets offset by strong growth in healthcare [16] - The Specialty Engineered Materials segment grew organic sales by 6%, driven by strong demand in defense and healthcare, with healthcare growing double digits [17][18] - Packaging Materials, the segment's largest end market, experienced muted sales growth, particularly in EMEA, despite overall EBITDA margin expansion of 100 basis points [16][20] Market Data and Key Metrics Changes - In the U.S. and Canada, sales increased 1% year over year, led by healthcare and defense, offsetting weaker demand in consumer and transportation markets [19] - EMEA sales were down slightly, with robust healthcare and defense sales but muted packaging sales [20] - Asia delivered 3% organic growth, marking the fifth consecutive quarter of growth, with strength in healthcare and transportation [20] Company Strategy and Development Direction - The company aims to evolve from a specialty formulator to an innovator of material solutions, with a focus on strategic structural changes in R&D to enhance product differentiation [9][11] - The operational playbook is designed to realize approximately $40 million in benefits for 2025, with a focus on sourcing, Lean Six Sigma, and manufacturing optimization [8][10] - The company is prioritizing investments in growth vectors, particularly in healthcare and defense, which are expected to drive future growth [12][18] Management's Comments on Operating Environment and Future Outlook - Management noted that market trends are not improving, with customers remaining in a wait-and-see mode, particularly in consumer markets [7][10] - The company expects Q3 to continue the trends observed in Q2, with consumer weakness anticipated to persist [7][45] - Despite challenges, management remains optimistic about strong demand in defense and healthcare, which are seen as bright spots for the business [7][18] Other Important Information - The company has already realized $17 million of the $40 million benefits targeted for 2025, with the remaining expected in the second half [8] - The company is on track to reduce total debt by $100 million to $200 million by year-end, having repaid $50 million in the second quarter [11][22] Q&A Session Summary Question: Is there any pre-buying activity affecting sales? - Management indicated no significant pre-buying activity has been observed, as customers are managing inventory tightly in the current uncertain demand environment [25][26] Question: What is the outlook for raw material inflation? - The company expects raw material inflation to remain at 1% to 2% for the year, with some fluctuations in specific materials [28][29] Question: What is the outlook for volume in the second half? - Management anticipates a continuation of trends from the first half, with consumer markets expected to decline and packaging to grow slightly [35][36] Question: How has consumer weakness evolved? - Consumer sales were flat in Q1 and down 8% in Q2, with significant weakness noted in the U.S. and Canada [44][45] Question: What is the impact of planned maintenance on EBITDA? - The planned maintenance in the SEM segment impacted EBITDA by approximately $3 million in Q2, but margins are expected to expand in the second half [46][80] Question: Are customers pressuring for tariff cost absorption? - Management acknowledged some pressure on pricing due to increased tariffs, but they are working with suppliers and customers to manage costs [50][51] Question: Can you provide context on healthcare growth? - Healthcare has shown strong growth, particularly in medical devices and drug delivery, with a positive outlook for continued demand [62][63] Question: What are the trends in key markets in China? - The color business in China is under pressure due to government policies, but growth is expected in the SEM side related to high-performance computing [66][68]

Financial Data and Key Metrics Changes - The company reported second quarter organic sales growth of 0.6% and adjusted EPS growth of 5% to $0.80, slightly ahead of guidance [6][11] - Adjusted EBITDA margin expanded by 30 basis points to 17.2%, driven by favorable mix and productivity initiatives [6][11] - For the first half of the year, organic sales grew about 1%, with expectations for a similar demand environment in the second half [7][11] Business Line Data and Key Metrics Changes - The Color Additives and Inks segment saw adjusted EBITDA grow 4% despite a 2% decline in organic sales, with weaker demand in consumer and transportation markets [16][17] - Specialty Engineered Materials segment grew organic sales by 6%, driven by strong growth in defense and healthcare, with healthcare growing double digits [18][19] - Packaging Materials segment's sales were muted, but EBITDA margins expanded by 100 basis points through cost improvement initiatives [16][17] Market Data and Key Metrics Changes - In the U.S. and Canada, sales increased by 1% year over year, led by healthcare and defense, offsetting weaker demand in other sectors [20] - EMEA sales were slightly down, with robust healthcare and defense sales but muted packaging sales [21] - Latin America grew 6%, marking its sixth consecutive quarter of growth, while Asia delivered 3% organic growth [21] Company Strategy and Development Direction - The company aims to evolve from a specialty formulator to an innovator of material solutions, with a focus on strategic structural changes in R&D to enhance product differentiation [10][12] - The operational playbook is designed to navigate low demand and high uncertainty, targeting approximately $40 million in benefits for 2025 [8][12] - Continued investment in growth vectors and strategic initiatives is prioritized, with a focus on healthcare, defense, and telecommunications as key growth drivers [12][19] Management's Comments on Operating Environment and Future Outlook - Management noted that market trends are not improving, with customers remaining in a wait-and-see mode, particularly in consumer markets [6][7] - The company expects Q3 to mirror Q2, with continued strength in defense and healthcare offsetting consumer weakness [7][22] - There is cautious optimism regarding the second half of the year, with expectations for adjusted EPS of $0.70, representing 8% growth year over year [22][23] Other Important Information - The company has a strong cash position, having paid down $50 million of debt during the quarter, and is on track to reduce total debt by $100 million to $200 million by year-end [12][23] - Patent filings increased by 50% in 2024 compared to 2023, indicating a focus on innovation [13] - The company expects CapEx for the year to be approximately $110 million and free cash flow to range from $190 million to $210 million [23] Q&A Session Summary Question: Is there any pre-buying activity affecting sales? - Management indicated no significant pre-buying activity has been observed, as customers are managing inventory tightly in uncertain demand environments [26][28] Question: What is the outlook for raw material inflation? - The company expects raw material inflation to remain at 1% to 2%, with some fluctuations in specific materials [30][31] Question: What is the outlook for volume in the second half? - Management expects a continuation of trends from the first half, with healthcare, defense, and telecommunications driving growth, while consumer and packaging markets may see slight declines [35][36] Question: How has consumer weakness evolved? - Consumer sales were flat in Q1 but down 8% in Q2, with significant weakness noted in the U.S. and Canada [45][46] Question: What is the impact of planned maintenance on EBITDA? - The planned maintenance impacted EBITDA by approximately $3 million in Q2, but margins are expected to expand in the second half [47][48] Question: Are customers pressuring to absorb tariff costs? - Management acknowledged pressure from customers regarding pricing due to increased tariffs, but they are working to manage costs and maintain pricing [51][52] Question: Can you provide context on the healthcare growth? - Healthcare has shown strong growth, particularly in medical devices and drug delivery, with a long-term positive outlook [61][62] Question: What are the trends in key markets in China? - The color business in China is under pressure due to government policies, but growth is expected in high-performance computing [67][68]

Core Viewpoint - Avient (AVNT) reported quarterly earnings of $0.8 per share, exceeding the Zacks Consensus Estimate of $0.78 per share, and showing an increase from $0.76 per share a year ago, indicating a positive earnings surprise of +2.56% [1] Financial Performance - The company achieved revenues of $866.5 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.78% and showing growth from $849.7 million year-over-year [2] - Over the last four quarters, Avient has consistently surpassed consensus EPS estimates four times and topped revenue estimates two times [2] Stock Performance and Outlook - Avient shares have declined approximately 22.7% since the beginning of the year, contrasting with the S&P 500's gain of 7.8% [3] - The company's earnings outlook is crucial for assessing future stock performance, with current consensus EPS estimates at $0.67 for the coming quarter and $2.76 for the current fiscal year [7] Industry Context - The Zacks Chemical - Diversified industry, to which Avient belongs, is currently ranked in the bottom 5% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - The performance of Avient's stock may also be influenced by the overall industry outlook, as historical data indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

Q2 2025 Performance - Sales reached $867 million, reflecting a 2% increase compared to Q2 2024 [9] - Adjusted EBITDA was $149 million, a 3.9% increase year-over-year [9] - Adjusted EPS increased by 5.3% to $0.80 [9] - Adjusted EBITDA margin was 17.2% [10] Segment Performance - Color, Additives & Inks sales were $539 million, a 1% decrease, but adjusted EBITDA margin expanded by 100 bps to 20.9% [20] - Specialty Engineered Materials sales increased by 7% to $330 million, but adjusted EBITDA margin decreased to 19% [23] Regional Growth - Organic revenue growth by region: US & Canada +1%, Europe, Middle East & Africa -1%, Asia +3%, Latin America +6% [25] Full Year 2025 Guidance - Adjusted EBITDA is projected to be between $545 million and $560 million, representing a 4% to 6% growth excluding foreign exchange impact [28] - Adjusted EPS is expected to be between $2.77 and $2.87 for the full year [28] - Free Cash Flow is expected to be $190 million to $210 million for FY 2025 [16] Productivity and Debt Reduction - $40 million of full year YoY productivity benefits more than offset inflation & investments in growth vectors [14] - $50 million debt reduction in Q2; expect $100 million to $200 million total debt reduction by year end [16]

Core Insights - Avient Corporation reported second quarter sales of $866.5 million, reflecting a 2% increase from $849.7 million in the same quarter of the previous year [1][6] - The company achieved GAAP earnings per share (EPS) of $0.57, up from $0.36 in the prior year quarter, and adjusted EPS of $0.80, representing a 5% growth [2][6] - The CEO highlighted organic revenue growth for the fifth consecutive quarter, driven by strong operational performance and customer focus, despite mixed demand conditions across various markets [3][5] Financial Performance - Second quarter adjusted EBITDA margins expanded by 30 basis points to 17.2% [3] - The company narrowed its full-year guidance for adjusted EBITDA to a range of $545 to $560 million and adjusted EPS to $2.77 to $2.87 [4] - Strong cash flow from operations was reported at $113 million, supporting a $50 million debt repayment, with plans to reduce total debt by $100 million to $200 million by year-end [4][6] Market Conditions - Demand conditions were mixed, with resilient growth in defense and healthcare sectors, while consumer demand remained weak [3][5] - The company is monitoring the evolving trade environment and expects minimal direct impact from tariffs due to local sourcing and manufacturing [5] Segment Performance - Sales in the Color, Additives and Inks segment were $538.6 million, while Specialty Engineered Materials reported $329.7 million in sales [24] - The gross margin for the second quarter was $277.9 million, compared to $257.6 million in the prior year quarter [27] Outlook - The company anticipates similar demand trends in the second half of the year, with continued momentum from high-profit portfolios in defense and healthcare markets [4] - Adjusted EPS for the third quarter is expected to be $0.70, representing an 8% growth over the prior year quarter [4]

[Second Quarter 2025 Results Overview](index=1&type=section&id=Second_Quarter_2025_Results_Overview) This section covers Avient's Q2 2025 financial performance, management commentary, and business outlook, highlighting key financial metrics and strategic direction [Q2 2025 Financial Highlights](index=1&type=section&id=Q2%202025%20Financial%20Highlights) Avient reported increased sales and EPS for Q2 2025, with adjusted EPS exceeding guidance, driven by organic revenue growth and strong operational performance. The company also narrowed its full-year adjusted EPS guidance and made significant debt repayments Q2 2025 Key Financial Metrics | Metric | Q2 2025 | Q2 2024 | Change | | :----- | :------ | :------ | :----- | | Sales | $866.5 million | $849.7 million | +2.0% | | GAAP EPS | $0.57 | $0.36 | +58.3% | | Adjusted EPS | $0.80 | $0.76 | +5.3% | - Second quarter sales of **$867 million** reflect **2% growth** over the prior year quarter and includes a **favorable impact of 1%** from foreign exchange[5](index=5&type=chunk) - Second quarter 2025 GAAP EPS includes special items of **$0.07** and **$0.16** of intangible amortization expense[2](index=2&type=chunk) - Second quarter 2025 adjusted EPS includes a **favorable impact of $0.01** attributable to foreign exchange[3](index=3&type=chunk) 2025 Full-Year Adjusted EPS Guidance | Metric | Previous Guidance | New Guidance | | :----- | :---------------- | :----------- | | 2025 Full-Year Adjusted EPS | $2.70 to $2.94 | $2.77 to $2.87 | - Strong cash flow from operations of **$113 million** in the quarter supported **$50 million of debt repayment**; on-track to reduce debt in total by **$100 million to $200 million** by year-end[5](index=5&type=chunk) [Management Commentary and Business Outlook](index=1&type=section&id=Management%20Commentary%20and%20Business%20Outlook) Management highlighted mixed demand conditions, with resilience in defense and healthcare offsetting weakness in consumer markets, leading to expanded adjusted EBITDA margins. The company narrowed its full-year guidance for adjusted EBITDA and EPS and is on track for significant debt reduction - Demand conditions were mixed across end markets; defense and healthcare demand remained resilient, growing **double digits**, offsetting weak demand in consumer[6](index=6&type=chunk) - Adjusted EBITDA margins expanded **30 basis points** to **17.2%** in Q2 2025[6](index=6&type=chunk) - Company expects similar demand trends in the second half of the year, with momentum from high-profit portfolios in defense and healthcare markets[7](index=7&type=chunk) 2025 Full-Year Guidance Updates | Metric | Previous Guidance | New Guidance | | :----- | :---------------- | :----------- | | 2025 Full-Year Adjusted EBITDA | N/A | $545 to $560 million | | 2025 Full-Year Adjusted EPS | $2.70 to $2.94 | $2.77 to $2.87 | - For the third quarter, adjusted EPS is expected to be **$0.70**, representing **8% growth** over the prior year quarter, largely driven by higher margins[7](index=7&type=chunk) - Company is on track to reduce total debt by **$100 million to $200 million** by year-end, having already repaid **$50 million** in Q2[7](index=7&type=chunk) - Minimal direct impact from tariffs is expected as raw materials are primarily sourced and products manufactured locally[8](index=8&type=chunk) [Company Information](index=3&type=section&id=Company_Information) This section provides an overview of Avient Corporation's business, its focus on materials solutions and sustainability, and contact details for investor and media relations [About Avient](index=3&type=section&id=About_Avient) Avient Corporation is an innovator of materials solutions, focusing on customer success and sustainability. They offer a broad portfolio including colorants, advanced composites, functional additives, engineered materials, and Dyneema®, serving customers globally with over 9,000 employees - Avient Corporation (NYSE: AVNT) is an innovator of materials solutions focused on customer success and enabling a sustainable world[15](index=15&type=chunk) - The company harnesses the collective strength of more than **9,000 employees** worldwide[15](index=15&type=chunk) - Expanding portfolio includes colorants, advanced composites, functional additives, engineered materials, and Dyneema®, the world's strongest fiber™[15](index=15&type=chunk) [Investor and Media Contacts](index=5&type=section&id=Investor_and_Media_Contacts) Provides contact information for investor relations and corporate communications personnel at Avient Corporation - Investor Relations Contact: Giuseppe (Joe) Di Salvo, Vice President, Treasurer and Investor Relations, +1 440-930-1921, giuseppe.disalvo@avient.com[20](index=20&type=chunk) - Media Contact: Kyle G. Rose, Vice President, Corporate Communications, +1 440-930-3162, kyle.rose@avient.com[20](index=20&type=chunk) [GAAP Financial Statements](index=7&type=section&id=GAAP_Financial_Statements) This section presents Avient's unaudited condensed consolidated GAAP financial statements, including statements of income, balance sheets, and cash flows for specified periods [Condensed Consolidated Statements of Income](index=7&type=section&id=Condensed_Consolidated_Statements_of_Income) Presents the GAAP income statement for the three and six months ended June 30, 2025 and 2024, showing sales, gross margin, operating income, net income, and diluted earnings per share Condensed Consolidated Statements of Income (in millions, except per share data) | Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) | | :------------------------------------- | :----------------- | :----------------- | :------------------ | :------------------ | | Sales | $866.5 | $849.7 | $1,693.1 | $1,678.7 | | Gross margin | $277.9 | $257.6 | $541.1 | $535.8 | | Operating income | $96.1 | $72.5 | $96.8 | $166.5 | | Net income attributable to Avient common shareholders | $52.6 | $33.6 | $32.4 | $83.0 | | Diluted EPS | $0.57 | $0.36 | $0.35 | $0.90 | | Cash dividends declared per share | $0.2700 | $0.2575 | $0.5400 | $0.5150 | [Condensed Consolidated Balance Sheets](index=9&type=section&id=Condensed_Consolidated_Balance_Sheets) Provides the GAAP balance sheet as of June 30, 2025, and December 31, 2024, detailing current and non-current assets, liabilities, and shareholders' equity Condensed Consolidated Balance Sheets (in millions) | Metric | June 30, 2025 | December 31, 2024 | Change | | :-------------------------------- | :------------ | :---------------- | :----- | | Total assets | $6,133.3 | $5,811.1 | +$322.2 | | Total liabilities | $3,759.3 | $3,481.5 | +$277.8 | | Total equity | $2,374.0 | $2,329.6 | +$44.4 | | Cash and cash equivalents | $474.5 | $544.5 | -$70.0 | | Accounts receivable, net | $523.4 | $399.5 | +$123.9 | | Inventories, net | $387.5 | $346.8 | +$40.7 | | Long-term debt | $2,020.0 | $2,059.3 | -$39.3 | [Condensed Consolidated Statements of Cash Flows](index=10&type=section&id=Condensed_Consolidated_Statements_of_Cash_Flows) Outlines the GAAP cash flow statement for the six months ended June 30, 2025, and 2024, categorizing cash flows from operating, investing, and financing activities, showing a decrease in cash and cash equivalents Condensed Consolidated Statements of Cash Flows (in millions) | Metric | YTD 2025 (6 Months) | YTD 2024 (6 Months) | Change | | :-------------------------------- | :------------------ | :------------------ | :----- | | Net cash provided by operating activities | $61.7 | $63.1 | -$1.4 | | Net cash used by investing activities | ($39.5) | ($54.5) | +$15.0 | | Net cash used by financing activities | ($106.4) | ($54.8) | -$51.6 | | Decrease in cash and cash equivalents | ($70.0) | ($56.4) | -$13.6 | | Cash and cash equivalents at end of period | $474.5 | $489.4 | -$14.9 | [Non-GAAP Financial Measures and Reconciliations](index=3&type=section&id=Non_GAAP_Financial_Measures_and_Reconciliations) This section explains Avient's use of non-GAAP financial measures and provides detailed reconciliations to their GAAP equivalents for adjusted net income, EPS, operating income, and EBITDA [Explanation of Non-GAAP Financial Measures](index=3&type=section&id=Explanation_of_Non_GAAP_Financial_Measures) Avient uses various non-GAAP financial measures, such as adjusted EPS, adjusted EBITDA, and organic performance, to evaluate ongoing performance and allocate resources, believing these provide useful insights to investors by excluding certain variable items. The company does not provide forward-looking reconciliations due to inherent difficulties in forecasting certain items - Non-GAAP financial measures include organic performance, adjusted EPS, adjusted operating income, adjusted EBITDA, adjusted EBITDA margins, free cash flow, and adjusted free cash flow[12](index=12&type=chunk) - These measures are used by Avient's chief operating decision maker to monitor and evaluate performance and allocate resources, and are believed to be useful to investors for comparability[12](index=12&type=chunk) - The Company does not provide reconciliations of forward-looking non-GAAP financial measures to GAAP due to the inherent difficulty of forecasting the timing and amount of certain items[13](index=13&type=chunk) [Reconciliation of Adjusted Net Income and EPS](index=6&type=section&id=Reconciliation_of_Adjusted_Net_Income_and_EPS) Reconciles GAAP net income and EPS to adjusted net income and adjusted EPS for the three and six months ended June 30, 2025 and 2024, by adjusting for special items and intangible amortization expense Reconciliation of Adjusted Net Income and EPS (in millions, except per share data) | Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) | | :------------------------------------- | :----------------- | :----------------- | :------------------ | :------------------ | | Net income attributable to Avient common shareholders (GAAP) | $52.6 | $33.6 | $32.4 | $83.0 | | Special items, after-tax | $5.7 | $21.8 | $81.4 | $27.3 | | Amortization expense, after-tax | $15.2 | $14.8 | $29.7 | $29.7 | | Adjusted net income | $73.5 | $70.2 | $143.5 | $140.0 | | Diluted EPS (GAAP) | $0.57 | $0.36 | $0.35 | $0.90 | | Adjusted EPS | $0.80 | $0.76 | $1.56 | $1.52 | [Summary of Special Items](index=8&type=section&id=Summary_of_Special_Items) Details the impact of special items on cost of sales, selling and administrative expense, operating income, and net income for the three and six months ended June 30, 2025 and 2024, including restructuring costs, environmental remediation, and a significant cloud-based ERP system impairment in 2025 Summary of Special Items (in millions, except per share data) | Impact on | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) | | :------------------------------------- | :----------------- | :----------------- | :------------------ | :------------------ | | Cost of sales | ($3.8) | ($21.6) | ($11.5) | ($22.0) | | Selling and administrative expense | ($3.2) | ($5.6) | ($95.0) | ($11.4) | | Operating income | ($7.0) | ($27.2) | ($106.5) | ($33.4) | | Net income | ($5.7) | ($21.8) | ($81.4) | ($27.3) | | Diluted EPS impact | ($0.07) | ($0.24) | ($0.89) | ($0.30) | - Special items for YTD 2025 include a significant cloud-based enterprise resource planning system impairment of **$86.3 million impairment** within selling and administrative expense[28](index=28&type=chunk) - Special items are defined as charges related to specific strategic initiatives or financial restructuring, such as consolidation of operations, acquisition-related costs, employee separation costs, asset impairments, and environmental remediation costs[28](index=28&type=chunk) [Reconciliation of Adjusted Operating Income and EBITDA](index=12&type=section&id=Reconciliation_of_Adjusted_Operating_Income_and_EBITDA) Reconciles GAAP operating income to adjusted operating income and GAAP net income to EBITDA and adjusted EBITDA for the three and six months ended June 30, 2025 and 2024, by adding back special items, interest, taxes, depreciation, and amortization. Adjusted EBITDA margin for Q2 2025 was 17.2% Reconciliation of Adjusted Operating Income and EBITDA (in millions) | Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) | | :------------------------------------- | :----------------- | :----------------- | :------------------ | :------------------ | | Adjusted gross margin | $281.7 | $279.2 | $552.6 | $557.8 | | Adjusted gross margin as a percent of sales | 32.5% | 32.9% | 32.6% | 33.2% | | Adjusted operating income | $103.1 | $99.7 | $203.3 | $199.9 | | Adjusted operating income as a percent of sales | 11.9% | 11.7% | 12.0% | 11.9% | | EBITDA | $142.2 | $116.5 | $187.8 | $253.9 | | Adjusted EBITDA | $148.9 | $143.3 | $293.6 | $286.4 | | Adjusted EBITDA as a percent of sales | 17.2% | 16.9% | 17.3% | 17.1% | [Business Segment Operations](index=11&type=section&id=Business_Segment_Operations) This section details Avient's financial performance by business segment, including sales, operating income, and EBITDA for Color, Additives and Inks, and Specialty Engineered Materials [Segment Sales and Profitability](index=11&type=section&id=Segment_Sales_and_Profitability) Provides a detailed breakdown of sales, gross margin, selling and administrative expense, operating income, depreciation & amortization, and EBITDA by business segment for the three and six months ended June 30, 2025 and 2024. The Color, Additives and Inks segment showed slight sales growth and increased operating income, while Specialty Engineered Materials saw sales growth but a decrease in operating income Segment Sales (in millions) | Segment Sales (in millions) | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) | | :-------------------------- | :----------------- | :----------------- | :------------------ | :------------------ | | Color, Additives and Inks | $538.6 | $542.0 | $1,058.3 | $1,057.3 | | Specialty Engineered Materials | $329.7 | $308.1 | $638.1 | $622.5 | Segment Operating Income (in millions) | Segment Operating Income (in millions) | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) | | :------------------------------------- | :----------------- | :----------------- | :------------------ | :------------------ | | Color, Additives and Inks | $90.3 | $86.1 | $168.9 | $160.9 | | Specialty Engineered Materials | $40.2 | $42.8 | $87.3 | $96.2 | | Corporate | ($34.4) | ($56.4) | ($159.4) | ($90.6) | Segment EBITDA (in millions) | Segment EBITDA (in millions) | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) | | :--------------------------- | :----------------- | :----------------- | :------------------ | :------------------ | | Color, Additives and Inks | $112.7 | $107.9 | $213.0 | $204.6 | | Specialty Engineered Materials | $62.6 | $63.6 | $131.2 | $136.6 | | Corporate | ($32.6) | ($54.1) | ($155.5) | ($85.5) | [Legal and Disclaimers](index=2&type=section&id=Legal_and_Disclaimers) This section includes important legal disclaimers regarding forward-looking statements and provides details for accessing the Q2 2025 earnings webcast and conference call [Forward-Looking Statements](index=4&type=section&id=Forward_Looking_Statements) This section contains a standard disclaimer regarding forward-looking statements, outlining the various business risks and uncertainties, such as market disruptions, currency fluctuations, supply chain issues, regulatory changes, and raw material prices, that could cause actual results to differ materially from projections. The company undertakes no obligation to publicly update these statements - Statements not reported financial results are 'forward-looking statements' subject to business risks and uncertainties[17](index=17&type=chunk) - Factors causing actual results to differ include credit market volatility, currency fluctuations, tariffs, supply chain disruptions, regulatory changes, raw material prices, and demand for products[17](index=17&type=chunk) - The company undertakes no obligation to publicly update forward-looking statements[18](index=18&type=chunk) [Webcast and Conference Call Details](index=2&type=section&id=Webcast_and_Conference_Call_Details) Provides information on how to access the webcast and conference call for the Q2 2025 results and full-year outlook, scheduled for August 1, 2025, at 8:00 a.m. Eastern Time, including links for live viewing and pre-registration for Q&A. A recording will be available online for one year - Avient will provide additional details on its 2025 second quarter and full year outlook during its webcast scheduled for **8:00 a.m. Eastern Time** on **August 1, 2025**[9](index=9&type=chunk) - The webcast can be viewed live at avient.com/investors, and conference call participants should pre-register to receive dial-in information[10](index=10&type=chunk) - A recording of the webcast and slide presentation will be available at avient.com/investors/events-presentations for **one year**[11](index=11&type=chunk)

Company Overview - Avient (AVNT) is expected to report a year-over-year increase in earnings, with a projected quarterly earnings of $0.78 per share, reflecting a +2.6% change, and revenues of $851.39 million, up 0.2% from the previous year [3][12] Earnings Expectations - The earnings report is anticipated to be released on August 1, and the stock may rise if the results exceed expectations, while a miss could lead to a decline [2][12] - The consensus EPS estimate has been revised 1.66% lower in the last 30 days, indicating a reassessment by analysts [4] Earnings Surprise Prediction - The Most Accurate Estimate for Avient is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -1.22%, which suggests a bearish outlook from analysts [12] - The stock currently holds a Zacks Rank of 4 (Sell), complicating predictions for an earnings beat [12] Historical Performance - In the last reported quarter, Avient had an earnings surprise of +1.33%, with actual earnings of $0.76 per share against an expectation of $0.75 [13] - Over the past four quarters, Avient has beaten consensus EPS estimates four times [14] Industry Context - Huntsman (HUN), a competitor in the Zacks Chemical - Diversified industry, is expected to report a loss of $0.15 per share, marking a year-over-year decline of -207.1%, with revenues projected at $1.48 billion, down 5.8% [18] - Huntsman's consensus EPS estimate has been revised down by 35.3% in the last 30 days, but it currently has an Earnings ESP of +19.23%, despite a Zacks Rank of 5 (Strong Sell) [19]

Group 1 - The article highlights the top 100 sustainable companies identified by Calvert Research and Management based on an annual review of over 230 Environmental, Social, and Governance (ESG) performance indicators [1] - Key ESG performance indicators include workplace diversity, data security, and greenhouse-gas emissions [1] Group 2 - The article mentions a live video feature on Facebook called the Underdog Daily Dividend Show, which showcases portfolio candidates every trading day on the NYSE [2] - The show encourages audience interaction by allowing comments on favorite or least favorite stock tickers for potential inclusion in future reports [2]

Core Insights - Avient Corporation (AVNT) has launched ColorMatrix Amosorb Oxyloop-1, the first product in its new oxygen scavengers portfolio aimed at enhancing the recyclability of Polyethylene Terephthalate (PET) packaging [1][7] - The Oxyloop-1 grade has received endorsement from the European Platform for Bottle Packaging (EPBP), meeting high industry standards for recyclability and food contact regulatory requirements [2] - This non-nylon-based product is compatible with recycled PET, allowing for up to 100% recycled content, and is designed to maintain product freshness and shelf life [3][4] Product Features - Oxyloop-1 offers excellent oxygen scavenging performance, making it suitable for packaging applications such as juices and vitamin drinks [2][3] - The product maintains bottle clarity and reduces yellowing, enhancing aesthetic appeal while supporting sustainability goals [3][4] - Avient's commitment to reducing environmental impact is reflected in the introduction of this product, which aligns with brand owners' sustainability objectives [4] Market Performance - Avient's stock has decreased by 26.3% over the past year, while the industry has seen a decline of 17.8% [4] - The company currently holds a Zacks Rank of 3 (Hold), indicating a neutral outlook compared to better-ranked stocks in the Basic Materials sector [6]

Group 1 - Avient Corporation plans to release its second quarter 2025 earnings on August 1, 2025, before the market opens [1] - A webcast with a slide presentation will be hosted at 8:00 a.m. Eastern Time on the same day [1] - Participants in the conference call must pre-register to receive the dial-in number and personal PIN for the Q&A session [2] Group 2 - A recording of the webcast and the slide presentation will be available on the company's investor website immediately after the conference call and will remain accessible for one year [3] - Avient Corporation focuses on being an innovator of materials solutions, aiming to help customers succeed while promoting sustainability [4] - The company employs over 9,000 employees globally, leveraging their collective strength to innovate solutions that address customer challenges and capitalize on market opportunities [4]